OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Inflammatory Chemokine CCL5 and Cancer Progression
Donatella Aldinucci, Alfonso Colombatti
Mediators of Inflammation (2014) Vol. 2014, pp. 1-12
Open Access | Times Cited: 393

Showing 1-25 of 393 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1577

EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez‐Carmona, Julien Lesage, Didier Cataldo, et al.
Molecular Oncology (2017) Vol. 11, Iss. 7, pp. 805-823
Open Access | Times Cited: 487

Chemokines in Cancer
Melvyn T. Chow, Andrew D. Luster
Cancer Immunology Research (2014) Vol. 2, Iss. 12, pp. 1125-1131
Open Access | Times Cited: 437

Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 433

Senescent Cells in Cancer Therapy: Friends or Foes?
Boshi Wang, Jaskaren Kohli, Marco Demaria
Trends in cancer (2020) Vol. 6, Iss. 10, pp. 838-857
Open Access | Times Cited: 383

Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 303

The CCL5/CCR5 Axis in Cancer Progression
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
Cancers (2020) Vol. 12, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 301

Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
Shipra Das, Beny Shapiro, Emily Vucic, et al.
Cancer Research (2020) Vol. 80, Iss. 5, pp. 1088-1101
Open Access | Times Cited: 266

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Annie A. Wu, Virginia E. Drake, Amy Huang, et al.
OncoImmunology (2015) Vol. 4, Iss. 7, pp. e1016700-e1016700
Open Access | Times Cited: 242

CCL5/CCR5 axis in human diseases and related treatments
Zhen Zeng, Tianxia Lan, Yuquan Wei, et al.
Genes & Diseases (2021) Vol. 9, Iss. 1, pp. 12-27
Open Access | Times Cited: 206

CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Andrea Walens, Ashley V. DiMarco, Ryan Lupo, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 168

The Role of the Estrogen Pathway in the Tumor Microenvironment
Natalie J. Rothenberger, Ashwin Somasundaram, Laura P. Stabile
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 611-611
Open Access | Times Cited: 167

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment
Magnus T. Dillon, Katharina Bergerhoff, Malin Pedersen, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 11, pp. 3392-3403
Open Access | Times Cited: 166

Identification of Functionally Distinct Mx1+αSMA+ Periosteal Skeletal Stem Cells
Laura Ortinau, Hamilton Wang, Kevin Lei, et al.
Cell stem cell (2019) Vol. 25, Iss. 6, pp. 784-796.e5
Open Access | Times Cited: 164

The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved
Francesca Coperchini, Luca Chiovato, Gianluca Ricci, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 58, pp. 82-91
Open Access | Times Cited: 124

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
Ajaz A. Bhat, Sabah Nisar, Selma Maacha, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 109

Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy
Chao Gao, Keman Cheng, Yao Li, et al.
Nano Letters (2022) Vol. 22, Iss. 22, pp. 8801-8809
Closed Access | Times Cited: 78

The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials
Hongliang Duan, Lijuan Wang, Mingmei Huangfu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115276-115276
Open Access | Times Cited: 55

CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions
C Blattner, Viktor Fleming, Rebekka Weber, et al.
Cancer Research (2018) Vol. 78, Iss. 1, pp. 157-167
Open Access | Times Cited: 151

CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
Santosh Kumar Singh, Manoj K. Mishra, Isam-Eldin Eltoum, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 147

Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
Elisabetta Marcuzzi, Roberta Angioni, Barbara Molon, et al.
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 96-96
Open Access | Times Cited: 142

Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases
Joseph L. Sottnik, Jinlu Dai, Honglai Zhang, et al.
Cancer Research (2015) Vol. 75, Iss. 11, pp. 2151-2158
Open Access | Times Cited: 136

Enhancing Tumor T Cell Infiltration to Enable Cancer Immunotherapy
Jin Zhang, Stefan Endres, Sebastian Kobold
Immunotherapy (2019) Vol. 11, Iss. 3, pp. 201-213
Closed Access | Times Cited: 127

Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
Donatella Aldinucci, Naike Casagrande
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1477-1477
Open Access | Times Cited: 125

Page 1 - Next Page

Scroll to top